These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34095254)

  • 21. Catheter ablation as first-line treatment for paroxysmal atrial fibrillation: a systematic review and meta-analysis.
    Imberti JF; Ding WY; Kotalczyk A; Zhang J; Boriani G; Lip G; Andrade J; Gupta D
    Heart; 2021 Oct; 107(20):1630-1636. PubMed ID: 34261737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sex difference in atrial fibrillation recurrence after catheter ablation and antiarrhythmic drugs.
    Park YJ; Park JW; Yu HT; Kim TH; Uhm JS; Joung B; Lee MH; Pak HN
    Heart; 2023 Mar; 109(7):519-526. PubMed ID: 35332048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ablation Versus Antiarrhythmic Drugs as First-Line Therapy for Treatment-Naive Atrial Fibrillation: A Systematic Review and Meta-Analysis.
    Ullah W; Johnson D; Nair AS; Dikdan SJ; Frankel E; Humayun W; Pavri BB; Frisch D
    Am J Cardiol; 2024 Feb; 213():63-68. PubMed ID: 38040282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of atrial fibrillation recurrence after atrial fibrillation ablation with cryoballoon.
    Evranos B; Aytemir K; Oto A; Okutucu S; Karakulak U; Şahiner L; Kaya B; Kabakçı G
    Cardiol J; 2013; 20(3):294-303. PubMed ID: 23788304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Catheter ablation of inducible atrial flutter, in combination with atrial pacing and antiarrhythmic drugs ("hybrid therapy") improves rhythm control in patients with refractory atrial fibrillation.
    Prakash A; Saksena S; Krol RB; Filipecki A; Philip G
    J Interv Card Electrophysiol; 2002 Jun; 6(2):165-72. PubMed ID: 11992027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ablation versus medication as initial therapy for paroxysmal atrial fibrillation: An updated meta-analysis of randomized controlled trials.
    Kewcharoen J; Prasitlumkum N; Chokesuwattanaskul R; Yi R; Jongnarangsin K; Bunch TJ; Ranjan R; Navaravong L
    J Arrhythm; 2021 Dec; 37(6):1448-1458. PubMed ID: 34887949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Catheter ablation of atrial fibrillation in patients with left ventricular systolic dysfunction: a systematic review and meta-analysis.
    Anselmino M; Matta M; D'Ascenzo F; Bunch TJ; Schilling RJ; Hunter RJ; Pappone C; Neumann T; Noelker G; Fiala M; Bertaglia E; Frontera A; Duncan E; Nalliah C; Jais P; Weerasooriya R; Kalman JM; Gaita F
    Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1011-8. PubMed ID: 25262686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cryoballoon vs. radiofrequency ablation for paroxysmal atrial fibrillation: an updated meta-analysis of randomized and observational studies.
    Buiatti A; von Olshausen G; Barthel P; Schneider S; Luik A; Kaess B; Laugwitz KL; Hoppmann P
    Europace; 2017 Mar; 19(3):378-384. PubMed ID: 27702864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence-based insights on ideal blanking period duration following atrial fibrillation catheter ablation.
    Saglietto A; Ballatore A; Xhakupi H; Rubat Baleuri F; Magnano M; Gaita F; De Ferrari GM; Anselmino M
    Europace; 2022 Dec; 24(12):1899-1908. PubMed ID: 35917218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advanced electrophysiologic mapping systems: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(8):1-101. PubMed ID: 23074499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Need for ongoing anti arrhythmic drugs after ablation of atrial fibrillation. Review.
    Salghetti F; Vizzardi E; Elmaghawry M; Mamedouv R; D'Aloia A; Bonadei I; Sciatti E; Lipari A; Cerini M; Bontempi L; Metra M; Curnis A
    Recent Pat Cardiovasc Drug Discov; 2013 Dec; 8(3):204-15. PubMed ID: 24359232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benefits and risks of additional ablation of complex fractionated atrial electrograms for patients with atrial fibrillation: a systematic review and meta-analysis.
    Wu SH; Jiang WF; Gu J; Zhao L; Wang YL; Liu YG; Zhou L; Gu JN; Xu K; Liu X
    Int J Cardiol; 2013 Oct; 169(1):35-43. PubMed ID: 24083885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes of catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: a systematic review and meta-analysis.
    Zhao DS; Shen Y; Zhang Q; Lin G; Lu YH; Chen BT; Shi LS; Huang JF; Lu HH
    Europace; 2016 Apr; 18(4):508-20. PubMed ID: 26612881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of Catheter Ablation and Reduced Incidence of Dementia among Patients with Atrial Fibrillation during Long-Term Follow-Up: A Systematic Review and Meta-Analysis of Observational Studies.
    Saglietto A; Ballatore A; Xhakupi H; De Ferrari GM; Anselmino M
    J Cardiovasc Dev Dis; 2022 Apr; 9(5):. PubMed ID: 35621851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiofrequency catheter ablation maintains its efficacy better than antiarrhythmic medication in patients with paroxysmal atrial fibrillation: On-treatment analysis of the randomized controlled MANTRA-PAF trial.
    Raatikainen MJ; Hakalahti A; Uusimaa P; Nielsen JC; Johannessen A; Hindricks G; Walfridsson H; Pehrson S; Englund A; Hartikainen J; Kongstad O; Mortensen LS; Hansen PS;
    Int J Cardiol; 2015 Nov; 198():108-14. PubMed ID: 26163901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and Safety of High-Power Short-Duration Radiofrequency Catheter Ablation of Atrial Fibrillation.
    Park JW; Yang SY; Kim M; Yu HT; Kim TH; Uhm JS; Joung B; Lee MH; Pak HN
    Front Cardiovasc Med; 2021; 8():709585. PubMed ID: 34692779
    [No Abstract]   [Full Text] [Related]  

  • 37. Short-term Antiarrhythmic Drugs After Catheter Ablation for Atrial Fibrillation: A Meta-analysis of Randomized Controlled Trials.
    Xu B; Peng F; Tang W; Du Y; Guo H
    Ann Pharmacother; 2016 Sep; 50(9):697-705. PubMed ID: 27317015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Racial/Ethnic and Socioeconomic Disparities in Management of Incident Paroxysmal Atrial Fibrillation.
    Eberly LA; Garg L; Yang L; Markman TM; Nathan AS; Eneanya ND; Dixit S; Marchlinski FE; Groeneveld PW; Frankel DS
    JAMA Netw Open; 2021 Feb; 4(2):e210247. PubMed ID: 33635328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiarrhythmic drug therapy and catheter ablation in patients with paroxysmal or persistent atrial fibrillation: a systematic review and meta-analysis.
    Chander S; Kumari R; Luhana S; Shiwlani S; Parkash O; Sorath F; Wang HY; Tan S; Rahaman Z; Mohammed YN; Lohana AC; Sakshi F; Vaish E; Sadarat F
    BMC Cardiovasc Disord; 2024 Jun; 24(1):321. PubMed ID: 38918704
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.